G
George Poy
Publications - 2
Citations - 529
George Poy is an academic researcher. The author has contributed to research in topics: Tubulin & Point mutation. The author has an hindex of 2, co-authored 2 publications receiving 517 citations.
Papers
More filters
Journal ArticleDOI
A common pharmacophore for epothilone and taxanes: Molecular basis for drug resistance conferred by tubulin mutations in human cancer cells
Paraskevi Giannakakou,Rick Gussio,Eva Nogales,Kenneth H. Downing,Daniel W. Zaharevitz,Birgit Bollbuck,George Poy,Dan L. Sackett,Kyriacos C. Nicolaou,Tito Fojo +9 more
TL;DR: The unification of taxane, epothilone, and sarcodictyin chemistries in a single pharmacophore provides a framework to study drug-tubulin interactions that should assist in the rational design of agents targeting tubulin.
Journal ArticleDOI
Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer
Paraskevi Giannakakou,George Poy,Zhirong Zhan,Turid Knutsen,Mikhail V. Blagosklonny,Tito Fojo +5 more
TL;DR: While PTX resistance is primarily conferred by the tubulin mutations, the loss of functional p53 observed in all clones suggests that this loss may facilitate the development of resistance potentially by providing a clonal advantage which promotes the isolation of paclitaxel resistant cells.